These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 6193997)

  • 1. In vivo and in vitro inhibition of histamine release by calcium antagonists.
    Norn S; Jensen C; Stahl Skov P
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():394-7. PubMed ID: 6193997
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of calcium antagonists on histamine release from human leukocytes. In vivo and in vitro experiments.
    Jensen C; Stahl Skov P; Norn S
    Allergy; 1983 May; 38(4):233-7. PubMed ID: 6191589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of allergic histamine release by calcium antagonists.
    Chand N; Pillar J; Diamantis W; Sofia RD
    Eur J Pharmacol; 1985 Jan; 107(3):353-8. PubMed ID: 2579830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of calcium channel blockers on histamine liberation from isolated basophils and bronchial reactivity in patients with bronchial asthma].
    Hofman J; Siergiejko Z; Rutkowski R; Michalska I; Chyrek-Borowska S
    Pol Tyg Lek; 1990 Apr 2-9; 45(14-15):280-2. PubMed ID: 1700401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of nimodipine, verapamil and lanthanum on histamine release from human basophils: effect of pretreatment with sialidase.
    Jensen CB; Thastrup O; Norn S; Skov PS
    Pharmacol Toxicol; 1987 Mar; 60(3):214-6. PubMed ID: 2438678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deuterium-oxide-induced histamine release from basophils of allergic subjects. I. Responsiveness to deuterium oxide requires an activation step.
    Kazimierczak W; Plaut M; Knauer KA; Meier HL; Lichtenstein LM
    Am Rev Respir Dis; 1984 Apr; 129(4):592-6. PubMed ID: 6201094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of basophil histamine release by a haptenic peptide mixture prepared by chymotryptic hydrolysis of wheat flour.
    Tanabe S; Tesaki S; Yanagihara Y; Mita H; Takahashi K; Arai S; Watanabe M
    Biochem Biophys Res Commun; 1996 Jun; 223(3):492-5. PubMed ID: 8687423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of calcium entry blockers in several models of immediate hypersensitivity.
    Ritchie DM; Sierchio JN; Bishop CM; Hedli CC; Levinson SL; Capetola RJ
    J Pharmacol Exp Ther; 1984 Jun; 229(3):690-5. PubMed ID: 6202868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negligible effects of selective K(Ca) channel blockers on IgE-dependent histamine release from human basophils.
    Panesar PS; Ahad S; Gibbs BF
    Inflamm Res; 2009 Apr; 58 Suppl 1():26-7. PubMed ID: 19271128
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of smooth muscle calcium antagonists on human basophil histamine release.
    Middleton E; Drzewiecki G; Triggle D
    Biochem Pharmacol; 1981 Oct; 30(20):2867-9. PubMed ID: 6172129
    [No Abstract]   [Full Text] [Related]  

  • 11. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
    Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
    J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro and in vivo effect of corticosteroids on basophil releasability in patients with mild and severe bronchial asthma.
    Kivity S; Onn A; Agami O; Fireman E
    Clin Exp Allergy; 1997 Aug; 27(8):909-14. PubMed ID: 9291288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells and basophils: models for studying the antianaphylactic potency of drugs.
    Wahn U; Müller J
    Pediatr Pharmacol (New York); 1983; 3(3-4):287-92. PubMed ID: 6204269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased release of histamine in patients with respiratory symptoms related to perfume.
    Elberling J; Skov PS; Mosbech H; Holst H; Dirksen A; Johansen JD
    Clin Exp Allergy; 2007 Nov; 37(11):1676-80. PubMed ID: 17877753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histamine release test (HRT)].
    Yamatodani A
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():36-40. PubMed ID: 20941996
    [No Abstract]   [Full Text] [Related]  

  • 16. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine release from basophil leukocytes from HIV infected patients. In vitro studies of type I hypersensitivity reactions to microbial antigens, cytokines, and environmental antigens.
    Pedersen M
    Dan Med Bull; 1993 Jun; 40(3):286-94. PubMed ID: 7687946
    [No Abstract]   [Full Text] [Related]  

  • 18. [Characteristics of the effect of ketotifen on the selective and non-selective histamine release from human basophils].
    Gushchin IS; Zebrev AI
    Biull Eksp Biol Med; 1984 Jan; 97(1):60-3. PubMed ID: 6198010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein.
    Sarmiento EU; Espiritu BR; Gleich GJ; Thomas LL
    J Immunol; 1995 Aug; 155(4):2211-21. PubMed ID: 7543541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of basophils and mast cells in acute and late reactions in the skin.
    Charlesworth EN
    Chem Immunol; 1995; 62():84-107. PubMed ID: 7546286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.